| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629312 Reducing neuron damage caused by gp-120 protein in aids patients |
| 05/13/1997 | US5629309 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/13/1997 | US5629300 Drug containing (-)-metriphonate |
| 05/09/1997 | WO1997016729A1 Combinatorial dihydrobenzopyran library |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016451A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016429A1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
| 05/09/1997 | WO1997016418A1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same |
| 05/09/1997 | WO1997016190A1 Rotamase enzyme activity inhibitors |
| 05/09/1997 | WO1997016183A1 Thiamorphinans with neuroprotective activity |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236328A1 Rotamase enzyme activity inhibitors |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2232355A1 Thiamorphinans with neuroprotective activity |
| 05/07/1997 | EP0771801A1 Chromane derivatives |
| 05/07/1997 | EP0771800A2 Dioxino derivatives and their use as dopamine agonists |
| 05/07/1997 | EP0771798A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them |
| 05/07/1997 | EP0771791A1 Ethylamino carbazole melatonergic agents |
| 05/07/1997 | EP0771560A1 Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders |
| 05/07/1997 | EP0771323A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 05/07/1997 | EP0771198A1 Dihydro-2,3-benzodiazepine derivatives |
| 05/07/1997 | EP0771197A1 Use of heterocyclic compounds as dopamines-d 3? ligands |
| 05/07/1997 | EP0771196A1 Excitatory amino acid receptor antagonists |
| 05/07/1997 | EP0771191A1 Immunological activity of rhamnolipids |
| 05/07/1997 | EP0734385A4 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
| 05/07/1997 | EP0684951B1 Silylated acetylcholinesterase inhibitors |
| 05/07/1997 | EP0482084B1 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
| 05/07/1997 | CN1149295A Tricyclic Dicarbonyl derivatives |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/07/1997 | CN1148958A Pharmaceutical application of glucoside A and B of auricledleaf swallowort |
| 05/06/1997 | US5627300 Epilepsy, muscle relaxants |
| 05/06/1997 | US5627203 Tricyclic oxime ethers |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627177 Anxiolytic |
| 05/06/1997 | US5627168 Inhibition of the unidirectional efflux of the excitatory amino acid antagonist from the brain; antiepileptic and anxiolytic agents; schizophrenia, analgesics; neurodegenerative diseases |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/02/1997 | EP0770613A1 Substituted Imidazolidin-2,4-dione der4ivatives as immunomodulators |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770389A1 Use of monosialoganglioside GM1 or N-dichloro-acetyl-lyso-GM1 for preventing or reversing neuronal degeneration induced by a long term treatment with L-DOPA in the therapy of Parkinson's disease |
| 05/02/1997 | EP0770082A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770080A1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
| 05/02/1997 | EP0770077A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 05/02/1997 | EP0770076A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 05/02/1997 | EP0770068A1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 05/02/1997 | EP0770066A1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769965A1 Aqueous risperidone formulations |
| 05/02/1997 | EP0769961A1 Attenuation of wound healing processes |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/02/1997 | EP0769957A1 Methods for treating motor deficits |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769943A1 Methods of inhibiting demyelinating and dysmyelinating diseases |
| 05/02/1997 | EP0769937A1 Methods for inhibiting neuronal damage |
| 05/02/1997 | EP0707571B1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 05/02/1997 | EP0648202B1 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents |
| 05/02/1997 | EP0628039B1 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015596A1 Human pec-60-like protein and dna encoding the same |
| 05/01/1997 | WO1997015577A1 Reverse-turn mimetics and methods relating thereto |
| 05/01/1997 | WO1997015561A1 Chiral methyl phenyl oxazolidinones |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015550A1 Fluoro-substituted benzoylpropionic acid derivatives |
| 05/01/1997 | WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents |
| 05/01/1997 | WO1997015300A2 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
| 05/01/1997 | WO1997015225A1 Agent for treating neuro-degenerative disorders |
| 05/01/1997 | CA2233075A1 Fluoro-substituted benzoylpropionic acid derivatives |
| 05/01/1997 | CA2186412A1 Ethylamino carbazole melatonergic agents |
| 04/30/1997 | DE19539861A1 Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen Using 4-amino-4- (4-fluoro-benzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the sequelae of acute and chronic cerebral hypoperfusion and neurodegenerative diseases |
| 04/30/1997 | CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug |
| 04/30/1997 | CN1148854A Tropane-z-aldoxine derivatives and preparation process and use thereof |
| 04/30/1997 | CN1148807A Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 04/30/1997 | CN1148806A Transdermal delivery of anti-epileptic drugs |
| 04/30/1997 | CN1148594A Piperidyl methyl oxazolidinone |
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5624952 Vasoconstrictors |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624945 Use of riluzole for the treatment of neuro-aids |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | US5624927 N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624910 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
| 04/29/1997 | US5624682 Pharmaceutical formulations based on a ketoprofen solution in soft capsules, and processes for their preparation |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/28/1997 | CA2188908A1 Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014691A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 04/24/1997 | WO1997014684A1 Amino substituted pyrimidines and triazines |
| 04/24/1997 | WO1997014671A1 Cyclopentyl tachykinin receptor antagonists |